EQUITY RESEARCH MEMO

Peptech

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)65/100

PepTech Corporation is a US-based premium chemistry partner specializing in custom synthesis, specialty amino acids, and medicinal chemistry services for drug discovery. Founded in 1990 and ISO 9001 certified, the company operates R&D and manufacturing facilities in Shanghai and Dalian, China, serving a global customer base. As a critical enabler for pharmaceutical and biotech companies, PepTech provides essential building blocks and chemistry services that accelerate early-stage research through scale-up. The company benefits from the growing demand for peptide-based therapeutics and complex small molecules, positioning it well within the drug development supply chain. While private and without disclosed financials, PepTech's long-standing presence and strategic location in China offer cost advantages and operational reliability. The company's expertise in custom synthesis and medicinal chemistry makes it a key partner for organizations seeking specialized chemical support, driving steady demand and potential for growth.

Upcoming Catalysts (preview)

  • 2027Expansion of manufacturing capacity in China70% success
  • TBDStrategic partnership with a major pharmaceutical company60% success
  • TBDIncrease in outsourcing of peptide synthesis services due to market growth80% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)